Innate immune dysfunction and persistent activation in South African HIV elite controllers

BackgroundElite controllers can spontaneously control HIV-1 infection without antiretroviral treatment but remain at risk of developing non-AIDS-related conditions. The adaptive immune system is key in mediating spontaneous viral control; however, the innate immune response remains understudied. We...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Asisipo Mohamed, Yenzekile Zungu, Sharon Shalekoff, Osman Ebrahim, Ziyaad Waja, Neil Martinson, Caroline T. Tiemessen, Christina Thobakgale
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603436/full
_version_ 1849361998587887616
author Asisipo Mohamed
Asisipo Mohamed
Yenzekile Zungu
Yenzekile Zungu
Sharon Shalekoff
Sharon Shalekoff
Osman Ebrahim
Ziyaad Waja
Neil Martinson
Caroline T. Tiemessen
Caroline T. Tiemessen
Christina Thobakgale
Christina Thobakgale
author_facet Asisipo Mohamed
Asisipo Mohamed
Yenzekile Zungu
Yenzekile Zungu
Sharon Shalekoff
Sharon Shalekoff
Osman Ebrahim
Ziyaad Waja
Neil Martinson
Caroline T. Tiemessen
Caroline T. Tiemessen
Christina Thobakgale
Christina Thobakgale
author_sort Asisipo Mohamed
collection DOAJ
container_title Frontiers in Immunology
description BackgroundElite controllers can spontaneously control HIV-1 infection without antiretroviral treatment but remain at risk of developing non-AIDS-related conditions. The adaptive immune system is key in mediating spontaneous viral control; however, the innate immune response remains understudied. We assessed the quality of the innate immune responses by evaluating the phenotype and function of antigen-presenting cells (APCs) in South African adults living with HIV (PWH).MethodologyA total of 73 black South Africans were included in this study. Of these, 55 were living with HIV and included 16 individuals with spontaneous viral control (PWHEC), 20 HIV progressors (PWHPROG), and 19 individuals suppressed on ART (PWHART). Eighteen individuals without HIV infection (PWOHHIV-) served as the control group. Monocyte subsets, T cell and monocyte activation and the production of tumour necrosis factor-alpha (TNF-α), interferon-alpha (IFN-α), and interleukin-1 beta (IL-1β) by monocytes, myeloid (mDCs) and plasmacytoid (pDCs) dendritic cells were analyzed using multicolour flow cytometry following stimulation with toll-like receptor (TLR)4 (LPS), TLR7/8 (CL097), and TLR9 (CpG-ODN2216) ligands. Plasma biomarkers, soluble CD14 (sCD14), and D-dimer were assessed using enzyme-linked immunosorbent assay.ResultsOur findings show a reduced expression of CD86 on monocytes of PWHEC (p=0.04) compared to PWOHHIV-. A reduced frequency of the classical monocyte (CD14+CD16) subset in PWHEC (p=0.02) and PWHPROG (p=0.05) compared to PWOHHIV-. TNF-α and IL-1β production was lower in monocytes and mDCs of PWHEC compared to PWOHHIV- post-stimulation with TLR4, and TLR7/8 (all p<0.05). Increased sCD14 levels in PWHEC compared to PWOHHIV- (p=0.01) indicate persistent immune activation, whereas increased D-dimer levels in PWHPROG compared to PWHART (p=0.01) and PWHEC (p=0.04) suggest higher inflammation in PWHPROG.ConclusionPWHEC exhibits similar immune responses as other PWH including PWHPROG, their innate immune profiles are characterized by lower levels of monocyte activation, reduced levels of classical monocytes, reduced capacity to produce pro-inflammatory cytokines, and elevated biomarkers associated with unfavourable disease outcomes. These findings highlight the need for continuous monitoring and potential therapeutic interventions to mitigate chronic inflammation in PWHEC. Furthermore, it expands our understanding of complex innate immune cell responses in PWHEC.
format Article
id doaj-art-b3c1937dd5934d85ad2898fd75c20bf9
institution Directory of Open Access Journals
issn 1664-3224
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-b3c1937dd5934d85ad2898fd75c20bf92025-08-27T04:13:35ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-08-011610.3389/fimmu.2025.16034361603436Innate immune dysfunction and persistent activation in South African HIV elite controllersAsisipo Mohamed0Asisipo Mohamed1Yenzekile Zungu2Yenzekile Zungu3Sharon Shalekoff4Sharon Shalekoff5Osman Ebrahim6Ziyaad Waja7Neil Martinson8Caroline T. Tiemessen9Caroline T. Tiemessen10Christina Thobakgale11Christina Thobakgale12School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCentre for HIV and STIs, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCentre for HIV and STIs, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCentre for HIV and STIs, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaSchool of Therapeutic Sciences, Department of Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaPerinatal HIV Research Unit, Chris Hani Baragwanath Academic Hospital, Soweto, University of the Witwatersrand, Johannesburg,, South AfricaPerinatal HIV Research Unit, Chris Hani Baragwanath Academic Hospital, Soweto, University of the Witwatersrand, Johannesburg,, South AfricaSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCentre for HIV and STIs, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaSchool of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCentre for HIV and STIs, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaBackgroundElite controllers can spontaneously control HIV-1 infection without antiretroviral treatment but remain at risk of developing non-AIDS-related conditions. The adaptive immune system is key in mediating spontaneous viral control; however, the innate immune response remains understudied. We assessed the quality of the innate immune responses by evaluating the phenotype and function of antigen-presenting cells (APCs) in South African adults living with HIV (PWH).MethodologyA total of 73 black South Africans were included in this study. Of these, 55 were living with HIV and included 16 individuals with spontaneous viral control (PWHEC), 20 HIV progressors (PWHPROG), and 19 individuals suppressed on ART (PWHART). Eighteen individuals without HIV infection (PWOHHIV-) served as the control group. Monocyte subsets, T cell and monocyte activation and the production of tumour necrosis factor-alpha (TNF-α), interferon-alpha (IFN-α), and interleukin-1 beta (IL-1β) by monocytes, myeloid (mDCs) and plasmacytoid (pDCs) dendritic cells were analyzed using multicolour flow cytometry following stimulation with toll-like receptor (TLR)4 (LPS), TLR7/8 (CL097), and TLR9 (CpG-ODN2216) ligands. Plasma biomarkers, soluble CD14 (sCD14), and D-dimer were assessed using enzyme-linked immunosorbent assay.ResultsOur findings show a reduced expression of CD86 on monocytes of PWHEC (p=0.04) compared to PWOHHIV-. A reduced frequency of the classical monocyte (CD14+CD16) subset in PWHEC (p=0.02) and PWHPROG (p=0.05) compared to PWOHHIV-. TNF-α and IL-1β production was lower in monocytes and mDCs of PWHEC compared to PWOHHIV- post-stimulation with TLR4, and TLR7/8 (all p<0.05). Increased sCD14 levels in PWHEC compared to PWOHHIV- (p=0.01) indicate persistent immune activation, whereas increased D-dimer levels in PWHPROG compared to PWHART (p=0.01) and PWHEC (p=0.04) suggest higher inflammation in PWHPROG.ConclusionPWHEC exhibits similar immune responses as other PWH including PWHPROG, their innate immune profiles are characterized by lower levels of monocyte activation, reduced levels of classical monocytes, reduced capacity to produce pro-inflammatory cytokines, and elevated biomarkers associated with unfavourable disease outcomes. These findings highlight the need for continuous monitoring and potential therapeutic interventions to mitigate chronic inflammation in PWHEC. Furthermore, it expands our understanding of complex innate immune cell responses in PWHEC.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603436/fullHIV-1HIV elite controllersantigen-presenting cellsmonocyte activationproinflammatory cytokines
spellingShingle Asisipo Mohamed
Asisipo Mohamed
Yenzekile Zungu
Yenzekile Zungu
Sharon Shalekoff
Sharon Shalekoff
Osman Ebrahim
Ziyaad Waja
Neil Martinson
Caroline T. Tiemessen
Caroline T. Tiemessen
Christina Thobakgale
Christina Thobakgale
Innate immune dysfunction and persistent activation in South African HIV elite controllers
HIV-1
HIV elite controllers
antigen-presenting cells
monocyte activation
proinflammatory cytokines
title Innate immune dysfunction and persistent activation in South African HIV elite controllers
title_full Innate immune dysfunction and persistent activation in South African HIV elite controllers
title_fullStr Innate immune dysfunction and persistent activation in South African HIV elite controllers
title_full_unstemmed Innate immune dysfunction and persistent activation in South African HIV elite controllers
title_short Innate immune dysfunction and persistent activation in South African HIV elite controllers
title_sort innate immune dysfunction and persistent activation in south african hiv elite controllers
topic HIV-1
HIV elite controllers
antigen-presenting cells
monocyte activation
proinflammatory cytokines
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603436/full
work_keys_str_mv AT asisipomohamed innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT asisipomohamed innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT yenzekilezungu innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT yenzekilezungu innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT sharonshalekoff innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT sharonshalekoff innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT osmanebrahim innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT ziyaadwaja innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT neilmartinson innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT carolinettiemessen innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT carolinettiemessen innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT christinathobakgale innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers
AT christinathobakgale innateimmunedysfunctionandpersistentactivationinsouthafricanhivelitecontrollers